/Lists

Longevity Investors & VC Firms

373 firms in this list, with a median first check of $270K. 91 of them lead rounds. Generated from verified public data and updated continuously.

The March Group
DavisPre-Seed–Seed
24 people
HBM Healthcare Investments
ZugGrowth–Late Stage
8 people
Speciale Invest
ChennaiPre-Seed–Seed$100K – $1M
11 people
Black Jays Ventures
New YorkPre-Seed–Seed$250K – $500K
4 people
Merck Global Health Innovation Fund
RahwaySeed–Growth$10M
10 people
Hadean Ventures
OsloSeed–Growth
21 people
Kost Capital
FrederiksbergPre-Seed–Seed$270K – $1.1M
20 people
Miyako Capital
KyotoSeed–Series B
14 people
Terraflos Inc.
Seed
26 people
UCL Technology Fund
LondonPre-Seed–Series A$320K – $9M
13 people
Privilège Ventures
LuganoPre-Seed–Series A$100K – $1M
12 people
Dementia Discovery
LondonPre-Seed–Series A
26 people
Taihill Venture
BostonPre-Seed–Seed
11 people
Possible Ventures
MunichPre-Seed–Series B$100K – $5M
7 people
Qiming Venture Partners USA
CambridgeSeed–Series B
19 people
Vision Ventures
DammamPre-Seed–Seed
10 people
Spero Ventures
BurlingamePre-Seed–Series A$2M – $4M
6 people
WMU Biosciences Research & Commercialization Center
KalamazooPre-Seed–Series A$100K – $250K
12 people
Gore Range Capital
New YorkSeries A–Late Stage$500K – $5M
17 people
XGEN Venture
MilanPre-Seed–Series A
23 people
Maven Ventures
Palo AltoSeed$1M
4 people
Westlake Village BioPartners
Los AngelesPre-Seed–Series A$100K – $5M
13 people
Alkemi Growth Capital
New DelhiPre-Seed–Growth
17 people
DCVC Bio
Palo AltoSeed–Growth
14 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.